Provention bio announces leadership team expansion

Red bank, n.j. , dec. 20, 2021 /prnewswire/ -- december 20, 2021— provention bio, inc. (nasdaq: prvb) (the "company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the company has appointed christina yi as chief operations officer, responsible for manufacturing, supply chain and human resources, and benedict osorio as chief quality officer, responsible for all aspects of quality.
PRVB Ratings Summary
PRVB Quant Ranking